Blog
Io Biotech Posts Wider Loss in Q2
Io Biotech (NASDAQ:IOBT), a clinical-stage oncology company specializing in cancer vaccines, released its second quarter results on August 14, 2025. The most important update was the outcome of the
Actelis Networks Sales Plunge 73 Percent
Actelis Networks (NASDAQ:ASNS), a networking solutions provider specializing in hybrid fiber and secure communications for government and industrial markets, reported its second quarter results on
Elutia (ELUT) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, Aug. 14, 2025 at 5 p.m. ET
Chief Executive Officer — Randy Mills
Source Fool.com
Pedevco Posts 41 Percent Sales Drop
Pedevco (NYSEMKT:PED), an independent oil and gas company focused in the Permian and D-J Basins, released its second quarter 2025 results on August 14, 2025. Both top- and bottom-line results (GAAP)
Century Reports Flat Loss in Fiscal Q2
Century Therapeutics (NASDAQ:IPSC), an early-stage biotechnology company pioneering cell therapies using induced pluripotent stem cell (iPSC) technology, reported its second quarter 2025 financial
CapsoVision Revenue Jumps 17 Percent
CapsoVision (NASDAQ:CV), a medical technology company focused on capsule endoscopy systems, released its second quarter 2025 results on August 14, 2025. The company posted a 17% rise in revenue
Origin ORGN Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 14, 2025 at 5 p.m. ET
Chief Executive Officer and Co-Founder — John Bissell
Source Fool.com
Origin Materials Slashes 2026 Forecast
Origin Materials (NASDAQ:ORGN) reported second quarter 2025 results on August 14, 2025, highlighting the commercial launch of its first PET bottle caps, revised manufacturing and financial guidance
Emmaus Sales Drop 48 Percent
Emmaus Life Sciences (OTC:EMMA), a biopharmaceutical company focused on therapies for rare diseases like sickle cell disease, reported its earnings for the second quarter of fiscal 2025 on August
BLNE Reports Results
Beeline Holdings (NASDAQ:BLNE) reported Q2 2025 results on August 14, 2025, marking its complete exit from spirits and a sole focus on digital mortgage and real estate equity products. The company
TMC Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 14, 2025 at 4:30 p.m. ET
Chief Executive Officer — Gerard Barron
Source Fool.com
Profound Medical Posts Wider Loss in Q2
Profound Medical (NASDAQ:PROF), a medical technology company specializing in minimally invasive prostate therapies, reported its GAAP financial results for Q2 2025 on August 14, 2025. The company
Sidus Space Revenue Jumps 36 Percent
Sidus Space (NASDAQ:SIDU) reported Q2 2025 earnings on August 14, 2025, with revenue rising 36% year over year to $1.3 million and a GAAP net loss of $5.6 million as the company continued to invest
GAMB Reports Earnings
Gambling.com Group(NASDAQ:GAMB) reported second quarter 2025 results on August 14, 2025, with revenue rising 30% year over year to $39.6 million and adjusted EBITDA increasing 22% year over year to
KORE (KORE) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 14, 2025 at 5 p.m. ET
Chief Executive Officer — Ron Totton
Source Fool.com
Kore Group EBITDA Jumps 46 Percent in Q2
Kore Group (NYSE:KORE), an independent provider of Internet of Things (IoT) connectivity and solutions, released its second quarter fiscal 2025 earnings on August 14, 2025. The company reported GAAP
Talphera Cuts Expenses 14 Percent
Talphera (NASDAQ:TLPH), a specialty pharmaceutical company developing therapies for medically supervised hospital settings, reported its second quarter 2025 results on August 14, 2025. The company
Metals Company Gets $85 Million Boost
The Metals Company (NASDAQ:TMC) reported second quarter 2025 results on August 14, highlighting a $23.6 billion combined net present value (NPV) for its key projects, a major $85.2 million strategic
zSpace Posts Flat Revenue in Fiscal Q2
zSpace (NASDAQ:ZSPC), a leader in augmented and virtual reality (AR/VR) education hardware and software, released its second quarter fiscal 2025 results on August 14, 2025. The most critical
Arcadia Biosciences Sales Up 11 Percent
Arcadia Biosciences (NASDAQ:RKDA), a consumer wellness beverage company known for the Zola coconut water brand, released its second quarter results on August 14, 2025. The company reported GAAP
Nuvve (NVVE) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 14, 2025, at 5 p.m. ET
Chief Executive Officer — Gregory Poilasne
Source Fool.com
Shiba Inu Is Sinking Today -- Is the Cryptocurrency a Buy Right Now?
Shiba Inu (CRYPTO: SHIB) is moving lower on Thursday. The cryptocurrency was down 7.3% over the past 24 hours of trading as of 5:15 p.m. ET -- a stretch that also saw Bitcoin fall 3.9% and Ethereum
BLIN Reports Results
Bridgeline Digital (NASDAQ:BLIN) reported fiscal third quarter 2025 results on August 14, 2025, highlighting $3.8 million in GAAP revenue, $3.1 million in GAAP subscription license revenue (81% of
Plus Therapeutics Posts Q2 Profit Jump
Plus Therapeutics (NASDAQ:PSTV), a clinical-stage biotech focused on radiotherapeutics and diagnostics for central nervous system cancers, reported its second quarter 2025 results on August 14
Xwell Posts 17% Revenue Drop in Q2
Xwell (NASDAQ:XWEL), best known for its airport wellness spas and health services, released its second quarter 2025 results on August 14, 2025. The release showed GAAP revenue of $7.7 million, down